E. I. Du Pont De Nemours And Company Patent Portfolio Statistics

E. I. Du Pont De Nemours And Company

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of E. I. Du Pont De Nemours And Company look like?

Total Applications: 12,175
Granted Patents: 6,590
Grant Index 66.84 %
Abandoned/Rejected Applications: 3,270 (33.16%)
In-Process Applications: 2,313
Average Grant Time: 2.73 Years
Average Office Actions: 1.53

Which Technology Area E. I. Du Pont De Nemours And Company is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1796 599
1621 Organic Chemistry 400
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 332
1762 Oraganic Chemistry, Polymers, Compositions 313
1711 Coating, Etching, Cleaning, Single Crystal Growth 291

How many patents are E. I. Du Pont De Nemours And Company filing every year?

Year Total Applications
2022 0*
2021 11*
2020 16
2019 29
2018 127

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of E. I. Du Pont De Nemours And Company in USPTO?

Publication number: US20220010330A1
Application number: 17/488,611

Abstract:
Compositions and methods for controlling pests are provided. The methods involve transforming organisms with a nucleic acid sequence encoding an insecticidal protein. In particular, the nucleic acid sequences are useful for preparing plants and microorganisms that possess insecticidal activity. Thus, transformed bacteria, plants, plant cells, plant tissues and seeds are provided. Compositions are insecticidal nucleic acids and proteins of bacterial species. The sequences find use in the construction of expression vectors for subsequent transformation into organisms of interest including plants, as probes for the isolation of other homologous (or partially homologous) genes. The pesticidal proteins find use in controlling, inhibiting growth or killing Lepidopteran, Coleopteran, Dipteran, fungal, Hemipteran and nematode pest populations and for producing compositions with insecticidal activity.

Publication date: 2022-01-13
Applicant: E. I. Du Pont De Nemours And Company
Inventors: Amy Lum


Publication number: US20220002821A1
Application number: 17/470,754

Abstract:
The invention provides DNA compositions that relate to transgenic insect resistant maize plants. Also provided are assays for detecting the presence of the maize DP-004114-3 event based on the DNA sequence of the recombinant construct inserted into the maize genome and the DNA sequences flanking the insertion site. Kits and conditions useful in conducting the assays are provided.

Publication date: 2022-01-06
Applicant: E. I. Du Pont De Nemours And Company
Inventors: M Nowatzki Timothy


Publication number: US20210388039A1
Application number: 17/459,487

Abstract:
The disclosure relates to Bt toxin resistance management. One embodiment relates to the isolation and characterization of polynucleotides and polypeptides corresponding to novel Bt toxin receptors. The polynucleotides and polypeptides are useful in identifying or designing novel Bt toxin receptor ligands including novel insecticidal toxins.

Publication date: 2021-12-16
Applicant: E. I. Du Pont De Nemours And Company
Inventors: Edward Mark Nelson


How are E. I. Du Pont De Nemours And Company’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/488,611 Insecticidal Proteins And Methods For Their Use OPAP Central, Docket
17/470,754 Maize Event Dp-004114-3 And Methods For Detection Thereof Docketed New Case – Ready for Examination OPAP Central, Docket
17/459,487 Bt Toxin Receptors And Methods Of Use Docketed New Case – Ready for Examination OPAP Central, Docket
17/390,312 Extruded Mat Docketed New Case – Ready for Examination OPAP Central, Docket